Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parathyroid Adenoma Detection With Rubidium Chloride Imaging: A Proof-of-Concept Study

NCT07099404 is registered in ClinicalTrials.gov with Matthieu Pelletier-Galarneau, MD MSc as lead sponsor.

NCT NCT07099404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parathyroid Adenoma Detection With Rubidium Chloride Imaging: A Proof-of-Concept Study
Lead sponsor
Matthieu Pelletier-Galarneau, MD MSc
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
September 30, 2028
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, primary, parathyroid adenomas